nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0935	0.12	CbGbCtD
Norfloxacin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.0728	0.0938	CbGbCtD
Norfloxacin—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0694	0.0894	CbGbCtD
Norfloxacin—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.068	0.0876	CbGbCtD
Norfloxacin—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0593	0.0764	CbGbCtD
Norfloxacin—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.051	0.0657	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0497	0.064	CbGbCtD
Norfloxacin—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0474	0.0611	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0474	0.0611	CbGbCtD
Norfloxacin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0356	0.0458	CbGbCtD
Norfloxacin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0285	0.0367	CbGbCtD
Norfloxacin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0228	0.0293	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0218	0.0281	CbGbCtD
Norfloxacin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0218	0.0281	CbGbCtD
Norfloxacin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0163	0.021	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.015	0.0193	CbGbCtD
Norfloxacin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0149	0.0192	CbGbCtD
Norfloxacin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0139	0.0179	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0111	0.0144	CbGbCtD
Norfloxacin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00637	0.00821	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00584	0.00752	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00398	0.00513	CbGbCtD
Norfloxacin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00115	0.244	CbGdCrCtD
Norfloxacin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000685	0.145	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000433	0.0913	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000432	0.0913	CbGdCrCtD
Norfloxacin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000432	0.0913	CbGdCrCtD
Norfloxacin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000297	0.0628	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000225	0.0476	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000225	0.0476	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000225	0.0476	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.044	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.044	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.044	CbGdCrCtD
Norfloxacin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000157	0.000716	CcSEcCtD
Norfloxacin—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000714	CcSEcCtD
Norfloxacin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000156	0.00071	CcSEcCtD
Norfloxacin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000156	0.00071	CcSEcCtD
Norfloxacin—Rash—Topotecan—peripheral nervous system neoplasm	0.000156	0.00071	CcSEcCtD
Norfloxacin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000155	0.000709	CcSEcCtD
Norfloxacin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000155	0.000709	CcSEcCtD
Norfloxacin—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000708	CcSEcCtD
Norfloxacin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000706	CcSEcCtD
Norfloxacin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000706	CcSEcCtD
Norfloxacin—Headache—Topotecan—peripheral nervous system neoplasm	0.000155	0.000705	CcSEcCtD
Norfloxacin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000154	0.000704	CcSEcCtD
Norfloxacin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000154	0.000704	CcSEcCtD
Norfloxacin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000154	0.000703	CcSEcCtD
Norfloxacin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000154	0.000703	CcSEcCtD
Norfloxacin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000154	0.000703	CcSEcCtD
Norfloxacin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000154	0.000701	CcSEcCtD
Norfloxacin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000154	0.000701	CcSEcCtD
Norfloxacin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000153	0.000699	CcSEcCtD
Norfloxacin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000153	0.000699	CcSEcCtD
Norfloxacin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000697	CcSEcCtD
Norfloxacin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000153	0.000697	CcSEcCtD
Norfloxacin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000697	CcSEcCtD
Norfloxacin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000697	CcSEcCtD
Norfloxacin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000153	0.000697	CcSEcCtD
Norfloxacin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000695	CcSEcCtD
Norfloxacin—Rash—Melphalan—peripheral nervous system neoplasm	0.000152	0.000695	CcSEcCtD
Norfloxacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000152	0.000694	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000692	CcSEcCtD
Norfloxacin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.000689	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000688	CcSEcCtD
Norfloxacin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000687	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000678	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000678	CcSEcCtD
Norfloxacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.000672	CcSEcCtD
Norfloxacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.000672	CcSEcCtD
Norfloxacin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.000669	CcSEcCtD
Norfloxacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.000669	CcSEcCtD
Norfloxacin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000147	0.000669	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000146	0.000667	CcSEcCtD
Norfloxacin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000146	0.000666	CcSEcCtD
Norfloxacin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000145	0.000663	CcSEcCtD
Norfloxacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000145	0.000663	CcSEcCtD
Norfloxacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000145	0.000661	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000657	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000655	CcSEcCtD
Norfloxacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000144	0.000655	CcSEcCtD
Norfloxacin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000143	0.000655	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000653	CcSEcCtD
Norfloxacin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000651	CcSEcCtD
Norfloxacin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000647	CcSEcCtD
Norfloxacin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000142	0.000647	CcSEcCtD
Norfloxacin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000645	CcSEcCtD
Norfloxacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000141	0.000645	CcSEcCtD
Norfloxacin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000141	0.000645	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000644	CcSEcCtD
Norfloxacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000643	CcSEcCtD
Norfloxacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00014	0.000639	CcSEcCtD
Norfloxacin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000638	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000637	CcSEcCtD
Norfloxacin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000138	0.00063	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000628	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000628	CcSEcCtD
Norfloxacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000627	CcSEcCtD
Norfloxacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000137	0.000624	CcSEcCtD
Norfloxacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000623	CcSEcCtD
Norfloxacin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000609	CcSEcCtD
Norfloxacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000607	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000602	CcSEcCtD
Norfloxacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000132	0.000601	CcSEcCtD
Norfloxacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000599	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000596	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000594	CcSEcCtD
Norfloxacin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000594	CcSEcCtD
Norfloxacin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00013	0.000593	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000591	CcSEcCtD
Norfloxacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000129	0.000589	CcSEcCtD
Norfloxacin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000129	0.000587	CcSEcCtD
Norfloxacin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000128	0.000585	CcSEcCtD
Norfloxacin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000581	CcSEcCtD
Norfloxacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000127	0.00058	CcSEcCtD
Norfloxacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.000579	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000576	CcSEcCtD
Norfloxacin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.000575	CcSEcCtD
Norfloxacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000126	0.000574	CcSEcCtD
Norfloxacin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000571	CcSEcCtD
Norfloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000125	0.00057	CcSEcCtD
Norfloxacin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000125	0.000569	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000569	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000566	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000566	CcSEcCtD
Norfloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000124	0.000565	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000564	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000563	CcSEcCtD
Norfloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000123	0.00056	CcSEcCtD
Norfloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000122	0.000558	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000554	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00055	CcSEcCtD
Norfloxacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000119	0.000544	CcSEcCtD
Norfloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.000542	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000542	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.00054	CcSEcCtD
Norfloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000118	0.000539	CcSEcCtD
Norfloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000538	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000537	CcSEcCtD
Norfloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000534	CcSEcCtD
Norfloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000533	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000533	CcSEcCtD
Norfloxacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000531	CcSEcCtD
Norfloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.00053	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000528	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000527	CcSEcCtD
Norfloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000115	0.000525	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000524	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000524	CcSEcCtD
Norfloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000114	0.000522	CcSEcCtD
Norfloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000114	0.000522	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000522	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000521	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000519	CcSEcCtD
Norfloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000114	0.000518	CcSEcCtD
Norfloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000517	CcSEcCtD
Norfloxacin—Rash—Vincristine—peripheral nervous system neoplasm	0.000113	0.000514	CcSEcCtD
Norfloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000113	0.000514	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000512	CcSEcCtD
Norfloxacin—Headache—Vincristine—peripheral nervous system neoplasm	0.000112	0.000511	CcSEcCtD
Norfloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000503	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000502	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000501	CcSEcCtD
Norfloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000493	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000493	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000107	0.000487	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000486	CcSEcCtD
Norfloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000106	0.000484	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000482	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00048	CcSEcCtD
Norfloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000104	0.000474	CcSEcCtD
Norfloxacin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000468	CcSEcCtD
Norfloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000102	0.000467	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000465	CcSEcCtD
Norfloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000458	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000456	CcSEcCtD
Norfloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	9.96e-05	0.000455	CcSEcCtD
Norfloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.95e-05	0.000454	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000454	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.91e-05	0.000452	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.00045	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000447	CcSEcCtD
Norfloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000445	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000444	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000441	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	9.62e-05	0.000439	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	9.57e-05	0.000437	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000436	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000433	CcSEcCtD
Norfloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	9.39e-05	0.000428	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.000428	CcSEcCtD
Norfloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	9.2e-05	0.00042	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.00042	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000417	CcSEcCtD
Norfloxacin—Rash—Etoposide—peripheral nervous system neoplasm	9.13e-05	0.000416	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.12e-05	0.000416	CcSEcCtD
Norfloxacin—Headache—Etoposide—peripheral nervous system neoplasm	9.07e-05	0.000414	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000414	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000412	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000411	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000408	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000408	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000406	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.9e-05	0.000406	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000404	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000401	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000396	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000393	CcSEcCtD
Norfloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	8.6e-05	0.000392	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000386	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000386	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000386	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000386	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000385	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000378	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000377	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000376	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000373	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000371	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.00037	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.00037	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000364	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000363	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000358	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000357	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000357	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000357	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000356	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000353	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.00035	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000345	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000343	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000343	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000337	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000335	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000335	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	7.29e-05	0.000332	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.000331	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.00033	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000329	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000327	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000326	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000322	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000319	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000317	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000312	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.00031	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000308	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000305	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000305	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000305	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000303	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000302	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000298	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000295	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000294	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000293	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000293	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000293	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000282	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.00028	CcSEcCtD
Norfloxacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000273	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000272	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000271	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000271	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000266	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000262	CcSEcCtD
Norfloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000253	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000252	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000246	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000245	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000242	CcSEcCtD
Norfloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000235	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000234	CcSEcCtD
Norfloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000233	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000233	CcSEcCtD
Norfloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000232	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000227	CcSEcCtD
Norfloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.00022	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000218	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000216	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000216	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000215	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000203	CcSEcCtD
Norfloxacin—Levofloxacin—ABCB1—peripheral nervous system neoplasm	2.95e-05	0.509	CrCbGaD
Norfloxacin—Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	2.85e-05	0.491	CrCbGaD
